A hybrid type of memory that blends the high density of DRAM (Dynamic Random-Access Memory) with the speed of SRAM (Static Random-Access Memory) is at the forefront of this effort. The project is ...

New additions are in bold.

The company reckons the drug could bring in $1.2 billion at its peak. If approved, imetelstat will enter an evolving MDS market, with its main rival considered to be Bristol-Myers Squibb's ...